Search

everythinglearnresearchcommunity

for

Search:↓

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Sebaceous glands can heal and regenerate after injury using their own stem cells and help from hair follicle cells.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Serum triglyceride levels are not linked to prostate cancer risk.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.